Sign in

CIK 0000320017

  • Non-accelerated filer
  • Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222343568
Phone
+1 908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
  1. 4 Grant or award Director acquired 12,121 shares (grant or award)
  2. 4 Shares withheld for taxes SVP and CFO gave up 1,795 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Executive Officer gave up 4,478 shares (to pay taxes)
  4. 4 Shares withheld for taxes See Remarks gave up 1,795 shares (to pay taxes)
  5. 4 Grant or award Director acquired 8,747 shares (grant or award)
  6. 4 Grant or award Director acquired 8,747 shares (grant or award)
  7. 4 Grant or award Director acquired 8,747 shares (grant or award)
  8. 4 Grant or award Director acquired 8,747 shares (grant or award)
  9. 4 Derivatives Options or other derivatives
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award SVP and CFO acquired 13,300 shares (grant or award)
  12. 4 Grant or award See Remarks acquired 13,300 shares (grant or award)
  13. 4 Grant or award Chief Executive Officer acquired 33,300 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Grant or award See Remarks acquired 13,300 shares (grant or award)
  18. 4 Grant or award Chief Executive Officer acquired 33,300 shares (grant or award)
  19. 4 Grant or award SVP and CFO acquired 13,300 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 6 of 33 · 648 filings